VESIVAX Trademark

Trademark Overview


On Friday, February 19, 1999, a trademark application was filed for VESIVAX with the United States Patent and Trademark Office. The USPTO has given the VESIVAX trademark a serial number of 75644067. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 1, 2022. This trademark is owned by Molecular Express, Inc.. The VESIVAX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines
vesivax

General Information


Serial Number75644067
Word MarkVESIVAX
Filing DateFriday, February 19, 1999
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 1, 2022
Registration Number2498737
Registration DateTuesday, October 16, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 7, 1999

Trademark Statements


Goods and Servicesvaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 2, 1999
Primary Code005
First Use Anywhere DateSunday, January 31, 1999
First Use In Commerce DateWednesday, February 28, 2001

Trademark Owner History


Party NameMOLECULAR GPS TECHNOLOGIES
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRANCHO DOMINGUEZ, CA 90220

Party NameMolecular Express, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90061

Party NameMolecular Express, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90061

Party NameMolecular Express, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90061

Trademark Events


Event DateEvent Description
Tuesday, March 1, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, March 1, 2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, March 1, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 1, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 7, 2021TEAS SECTION 8 & 9 RECEIVED
Friday, October 16, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, October 26, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 10, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, November 10, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, November 10, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 1, 2010TEAS SECTION 8 & 9 RECEIVED
Friday, January 25, 2008REGISTERED - SEC. 15 ACKNOWLEDGED
Tuesday, January 22, 2008ASSIGNED TO PARALEGAL
Friday, January 18, 2008TEAS SECTION 15 RECEIVED
Wednesday, December 12, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 26, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, June 25, 2007ASSIGNED TO PARALEGAL
Monday, June 4, 2007REGISTERED - SEC. 8 (6-YR) FILED
Monday, June 4, 2007PAPER RECEIVED
Friday, January 26, 2007CASE FILE IN TICRS
Tuesday, October 16, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2001ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 21, 2001ASSIGNED TO EXAMINER
Tuesday, May 15, 2001STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 3, 2001USE AMENDMENT FILED
Sunday, February 25, 2001EXTENSION 1 GRANTED
Friday, January 12, 2001EXTENSION 1 FILED
Tuesday, July 18, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 4, 2000EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 7, 1999PUBLISHED FOR OPPOSITION
Friday, November 5, 1999NOTICE OF PUBLICATION
Monday, July 26, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 22, 1999ASSIGNED TO EXAMINER

Related Keywords


vesivax vaccines